Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major ...

Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly delaying market entry of generic Pomalyst | Lawsuit follows dismissal of ...